Search - tctmd.com

Displaying 1 - 3 of 3

Sort: Relevancy | Date

News Daily News

NOBLE at 5 Years: New Data Favor CABG for Left Main Disease

December 23, 2019

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

News Daily News

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Michael O'Riordan

January 08, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.